Estrogen receptor beta expression in prostate adenocarcinoma

Diagnostic Pathology

Volumn 6, Issue 1, 2011, Pages

  Asgari, Mojgan ^a,b   Morakabati, Arman ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Ghom University of Medical Sciences   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR BETA; TUMOR MARKER;

ADENOCARCINOMA; AGED; ARTICLE; CANCER GRADING; CHEMISTRY; CHI SQUARE DISTRIBUTION; HUMAN; IMMUNOHISTOCHEMISTRY; IRAN; MALE; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PROSTATE TUMOR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CHI-SQUARE DISTRIBUTION; ESTROGEN RECEPTOR BETA; HUMANS; IMMUNOHISTOCHEMISTRY; IRAN; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79959910360     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-6-61     Document Type: Article

References (17)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. Cancer statistics. CA Cancer J Clin 2004, 54:8-29. 10.3322/canjclin.54.1.8, 14974761.
2. Amling CL, Kane CJ, Riffenburgh RH, Ward JF, Roberts JL, Lance RS, Friedrichs PA, Moul JW. Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. Urology 2001, 58(5):723-8. 10.1016/S0090-4295(01)01373-5, 11711349.
3. Berthon P, Valeri A, Cohen-Akenine A, Drelon E, Paiss T, Wöhr G, Latil A, Millasseau P, Mellah I, Cohen N, Blanché H, Bellané-Chantelot C, Demenais F, Teillac P, Le Duc A, de Petriconi R, Hautmann R, Chumakov I, Bachner L, Maitland NJ, Lidereau R, Vogel W, Fournier G, Mangin P, Cohen D, Cussenot O. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet 1998, 62(6):1416-24. 10.1086/301879, 1377158, 9585607.
4. Bonkhoff H, Fixemer T, Hunsicker I, Remberger K. Estrogen receptor expression in prostate cancer and premalignant prostatic lesions. Am J Pathol 1999, 155:641-647. 10.1016/S0002-9440(10)65160-7, 1866870, 10433957.
5. Santti R, Newbold RR, Makela S, Pylkkanen L, Mclachlan JA. Developmental estrogenization and prostatic neoplasia. Prostate 1994, 24:67-78. 10.1002/pros.2990240204, 7508622.
6. Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 1972, 22:232-240. 10.3322/canjclin.22.4.232, 4625049.
7. Torlakovic E, Lilleby W, Torlacovic G, Fossa SD, Chibbar R. Prostate carcinoma expresson of estrogen receptor-b as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score. Human Pathology 2002, 33(6):646-651. 10.1053/hupa.2002.124033, 12152165.
8. Dunsmuir WD, Gillett CE, Meyer LC, Young MP, Corbishley C, Beles RA, Kirby RS. Molecular markers fro predicting prostate cancer stage and survival. BJU international 2000, 86:869-876.
9. Pylkkanen L, Makela S, Santti R. Animal models for the preneoplastic lesions of the prostate. Eur Urol 1996, 30:243-248.
10. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996, 93:5925-5930. 10.1073/pnas.93.12.5925, 39164, 8650195.
11. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS. Differential ligand activation of estrogen receptors ER-a and ER-b at AP1 sites. Science 1997, 277:1508-1510. Wash. DC, 10.1126/science.277.5331.1508, 9278514.
12. Konrad KF, Luisa HA, Lars-Arne H, Margaret W, Jan-Åke G. Reflections on the Discovery and Significance of Estrogen Receptor -b. Endocrine Reviews 2005, 26(3):465-478. 10.1210/er.2004-0027, 15857973.
13. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O. Generation and reproductive phenotypes of mice lacking estrogen receptor b. Proc Natl Acad Sci USA 1998, 95:15677-15682. 10.1073/pnas.95.26.15677, 28103, 9861029.
14. Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, Singh H, Ho SM. Comparative studies of the estrogen receptors -a and -b and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol 2001, 159:79-92. 10.1016/S0002-9440(10)61676-8, 1850428, 11438457.
15. Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker PD, Grygiel JJ, Gustafsson JA, Sutherland RL. Frequent loss of estrogen receptor-b expression in prostate cancer. Cancer Res 2001, 61:5331-5335.
16. Fixemer T, Remberger K, Bonkhoff H. Differential expression of the estrogen receptor beta (ER-b) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. Prostate 2003, 54(2):79-87. 10.1002/pros.10171, 12497580.
17. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW. Selective loss of estrogen receptor b in malignant human colon. Cancer Res 2000, 60:245-248.